pamiparib
merck,beigene
['pamiparib']
ivy brain tumor center announces initial results of pamiparib in newly-diagnosed and recurrent glioblastoma at the european society for medical oncology (esmo) 2022 congress 
World News Guru is completely free and offers a broad range of media content from a varied and extensive range of sources.